Hans Mulder
- Pharmacology top 5%
- Oncology
- Molecular Biology
- Pediatrics, Perinatology and Child Health
- Geriatrics and Gerontology top 10%
- Co-authors
- Vera H.M. DeneerBob WilffertJesse J. SwenNienke J. de Boer‐VegerMarga NijenhuisGerard A. RongenRon H. N. van SchaikHenk‐Jan Guchelaar
- Topics
- Pharmacogenetics and Drug Metabolism (4 papers)Health Systems, Economic Evaluations, Quality of Life (2 papers)Pharmacology and Obesity Treatment (2 papers)
- Partner nations
- NetherlandsAustriaAustralia
In The Last Decade
Hans Mulder
8 papers receiving 332 citations
Peers
Comparison fields: 5 of 61
- Pharmacology 133
- Oncology 130
- Molecular Biology 85
- Pediatrics, Perinatology and Child Health 71
- Geriatrics and Gerontology 40
Countries citing papers authored by Hans Mulder
This map shows the geographic impact of Hans Mulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Mulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Mulder more than expected).
Fields of papers citing papers by Hans Mulder
This network shows the impact of papers produced by Hans Mulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Mulder. The network helps show where Hans Mulder may publish in the future.
Co-authorship network of co-authors of Hans Mulder
This figure shows the co-authorship network connecting the top 25 collaborators of Hans Mulder. A scholar is included among the top collaborators of Hans Mulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Mulder. Hans Mulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | [Discontinuation of SSRIs and SNRIs]. | 1 |
| 3 | 153 | |
| 4 | 69 | |
| 5 | 23 | |
| 6 | 18 | |
| 7 | 18 | |
| 8 | 24 |
About Hans Mulder
Hans Mulder is a scholar working on Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Pharmacology, having authored 8 papers that have together received 337 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Pharmacology (133 citations), Geriatrics and Gerontology (40 citations) and Oncology (130 citations). Hans Mulder has collaborated with scholars based in Netherlands, Austria and Australia. Frequent co-authors include Vera H.M. Deneer, Bob Wilffert, Jesse J. Swen, Nienke J. de Boer‐Veger, Marga Nijenhuis, Gerard A. Rongen, Ron H. N. van Schaik, Henk‐Jan Guchelaar, Elisa J. F. Houwink and Jan van der Weide. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Age and Ageing and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.